Skip to the main content.

1 min read

On Demand Webinar: Microbial In-Use Studies

Microbial in-use (admixture) studies are performed to evaluate the growth of low-level microorganisms inoculated into the diluted drug product and tested at several time points over the prescribed administration time.  These studies are performed to determine if microbial growth will be supported and/or proliferate in the product during the holding period prior to patient administration in the event of inadvertent microbial contamination during product dilution. It is important to understand and comply with the timelines and deadlines surrounding these microbiological procedures. 
 
In this webinar, Alcami’s admixture studies expert, Brent Harlow, will guide you through the necessity of these studies and how to successfully perform them for FDA approval. 
 
 
Microbial In-Use Studies On Demand (2)
 

Presentation Agenda:

  • Overview and Definitions
  • Time Frames for Performing Admixture Studies
  • FDA Filing and Approval Processes
  • Lessons Learned
  • Q & A Session Following Presentation  

Keynote Speaker:

  • Brent Harlow, Scientist

Q&A Expert:

  • Angela Harrison, Director of Microbiology

1 min read

QbD Addresses API Supply in Orphan Drug Formulation

According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those...

Read More

2 min read

Case Study: Challenges and Solutions to Formulating an Orphan Drug

According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status is applicable to drugs and biologics which are...

Read More

2 min read

EMPQ Case Study: Carolina Components Group

Read this case study to learn how Alcami supported Carolina Components Group in the successful completion of their comprehensive cleanroom...

Read More